Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Medicinova Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 30 | 30 | 0 |
| Shares | 4.93M | 5.23M | +301.8K (+6.1%) |
| Value | $10.4M | $11.0M | +$626.4K (+6.0%) |
New holders (5)
Institutions that held Medicinova Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SBI Securities Co., Ltd. | 53,771 | $112.9K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 36,957 | $77.6K | 0.01% |
| Group One Trading, L.P. | 1,400 | $2.94K | 0.00% |
| GWM Advisors LLC | 3 | $6 | 0.00% |
| Simplex Trading, LLC | 353 | $0 | 0.00% |
Sold out (5)
Institutions that held Medicinova Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Price T Rowe Associates Inc | 20,700 | $44.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 16,027 | $39.9K |
| Goldman Sachs Group Inc | 10,246 | $21.5K |
| Buckingham Strategic Partners | 10,000 | $21.0K |
| Citadel Advisors LLC | 1,431 | $3.00K |